Weight loss was significant in outcome trials, ranging from a 0.6 kg reduction at 12 weeks in the ELIXA trial to a 4.3 kg reduction at 2 years with injectable semaglutide in the SUSTAIN-6 trial
Reduced Sun Damage As an antioxidant, glutathione helps protect the skin from UV damage
GLP-1 receptor agonists, like Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for diabetes management, show promising potential in treating psoriasis and psoriatic arthritis (PsA)
Blood pressure medications, diuretics, and SGLT2 inhibitors may require dose adjustment as weight loss and improved insulin sensitivity occur
For label details on renal warnings, see the manufacturers Wegovy Prescribing Information
Stopping semaglutide would mean losing its blood sugarlowering effects, which is key for preventing complications from diabetes